debate about whether to use ezetimibe (Vytorin, Zetia) for dyslipidemia
December 2009
You'll hear more debate about whether to use ezetimibe (Vytorin, Zetia) for dyslipidemia.
Ezetimibe works well to lower LDL and is well tolerated...but it keeps coming up short in comparative trials.
The latest data suggest that ezetimibe doesn't reduce arterial plaque as well as niacin...when these drugs are added to a statin.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote